Synaptic plasticity lies at the heart of the brain's remarkable capacity to adapt and learn. It refers to the ability of synapses, the junctions between neurons, to undergo structural and functional changes in response to neuronal activity. Long-term potentiation (LTP) and long-term depression (LTD) are two primary forms of synaptic plasticity that play pivotal roles in learning and memory processes. LTP involves the strengthening of synaptic connections, leading to enhanced neuronal communication, while LTD results in the weakening of synaptic connections. These mechanisms underlie the brain's ability to encode and store information, forming the basis of learning and memory. Beyond its role in normal brain function, synaptic plasticity is implicated in various neurological and psychiatric disorders. Dysregulation of synaptic plasticity has been implicated in conditions such as Alzheimer's disease, schizophrenia, depression, and addiction, highlighting the importance of understanding these mechanisms in disease pathogenesis and treatment development. Researchers are exploring novel strategies to modulate synaptic plasticity for therapeutic purposes, aiming to restore normal synaptic function in diseased states. These efforts hold promise for the development of targeted interventions that address the underlying neural deficits associated with neurological and psychiatric disorders, ultimately improving patients lives.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom